
Matthew Roden
Entrepreneur Partner · MPM BioImpact
Venture Partner
Dr. Matthew Roden is an Entrepreneur Partner at MPM BioImpact and CEO of portfolio company Aktis Oncology. His career spans senior leadership in large pharma, healthcare equity capital markets and basic science, most recently as Senior Vice President and Head of Enterprise Strategy at Bristol Myers Squibb.
Board seats
10 current
· PUBLIC SOURCES
Credited hits
1
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Matthew Roden, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- Orna Therapeuticsacquired
Acquired by Eli Lilly, per MPM BioImpact team page; Roden previously served on its board.
Source: mpmbioimpact.com
Board seats
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
No reputation sources on file yet.
Suggest a sourceContact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- mpmbioimpact.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Matthew Roden. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Matthew Roden.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Matthew Roden — provenance: GlassVC catalog
↩ cites: Title · Firm · Type · Bio · Location · Credited deals · Board seats
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
